ISIS MEDICAL PARIS : revenue, balance sheet and financial ratios

ISIS MEDICAL PARIS is a French company founded 7 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in ROMAINVILLE (93230), this company of category ETI shows in 2020 a revenue of 2.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ISIS MEDICAL PARIS (SIREN 842109753)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C 2 864 146 € 1 076 692 €
Net income 607 274 € 297 000 € 339 084 € 554 761 € 365 250 € -382 125 €
EBITDA N/C N/C N/C N/C 764 918 € -273 489 €
Net margin N/C N/C N/C N/C 12.8% -35.5%

Revenue and income statement

In 2024, ISIS MEDICAL PARIS generates positive net income of 607 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

607 274 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 12%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

11.527%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

51.618%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

25.9%

Solvency indicators evolution
ISIS MEDICAL PARIS

Sector positioning

Debt ratio
11.53 2024
2022
2023
2024
Q1: 0.0
Med: 9.81
Q3: 79.47
Average -24 pts over 3 years

In 2024, the debt ratio of ISIS MEDICAL PARIS (11.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
51.62% 2024
2022
2023
2024
Q1: 5.79%
Med: 33.76%
Q3: 60.35%
Good +26 pts over 3 years

In 2024, the financial autonomy of ISIS MEDICAL PARIS (51.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 99.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

99.216

Liquidity indicators evolution
ISIS MEDICAL PARIS

Sector positioning

Liquidity ratio
99.22 2024
2022
2023
2024
Q1: 106.8
Med: 176.44
Q3: 303.96
Watch -18 pts over 3 years

In 2024, the liquidity ratio of ISIS MEDICAL PARIS (99.22) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
ISIS MEDICAL PARIS

Positioning of ISIS MEDICAL PARIS in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of ISIS MEDICAL PARIS is estimated at 2 440 869 € (range 955 120€ - 7 427 106€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
69 tx
955k€ 2440k€ 7427k€
2 440 869 € Range: 955 120€ - 7 427 106€
NAF 5 all-time

Valuation method used

Net Income Multiple
607 274 € × 4.0x = 2 440 870 €
Range: 955 120€ - 7 427 107€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare ISIS MEDICAL PARIS with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about ISIS MEDICAL PARIS

What is the revenue of ISIS MEDICAL PARIS ?

The revenue of ISIS MEDICAL PARIS in 2020 is 2.9 M€.

Is ISIS MEDICAL PARIS profitable?

Yes, ISIS MEDICAL PARIS generated a net profit of 607 k€ in 2024.

Where is the headquarters of ISIS MEDICAL PARIS ?

The headquarters of ISIS MEDICAL PARIS is located in ROMAINVILLE (93230), in the department Seine-Saint-Denis.

Where to find the tax return of ISIS MEDICAL PARIS ?

The tax return of ISIS MEDICAL PARIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ISIS MEDICAL PARIS operate?

ISIS MEDICAL PARIS operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.